logo image
search icon
date background image

Jul 10, 2024

Biospecimen Contract Research Services Market Set for Explosive Growth- 2024-2031 Forecast

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biospecimen Contract Research Services Market Size, Share & Trends Analysis Report By Biospecimen Type (Oncological Studies, Non-Oncological Studies), By Therapeutic Area(Oncological Disorders, Neurological Disorders, Cardiovascular Disorders Areas)- Market Outlook And Industry Analysis 2031"


The Global Biospecimen Contract Research Services Market is valued at US$ 4.38 Bn in 2023, and it is expected to reach US$ 11.70 Bn by 2031, with a CAGR of 13.37% during the forecast period of 2024-2031.


Request Complete FREE Sample Report Click Here: https://www.insightaceanalytic.com/request-sample/1264


The biospecimen contract research services (BCRS) market plays a pivotal role in facilitating research, drug development, and clinical trials by providing specialized expertise in the procurement, processing, storage, and analysis of biological materials derived from humans. These biospecimen, including tissue, blood, urine, and other bodily fluids, offer invaluable insights into the molecular mechanisms of diseases and are essential for advancing personalized therapies and precision medicine initiatives. The market's rapid growth is driven by increasing demand for high-quality biospecimens, the necessity to overcome capacity constraints, and the growing emphasis on personalized medicine approaches.


BCRS providers offer comprehensive support throughout the lifecycle of biospecimens, ensuring ethical acquisition, meticulous preparation, secure storage, and compliant distribution. These services cater to pharmaceutical companies, biotechnology firms, and academic institutions involved in medical research, facilitating biomarker identification, genetic testing, development of diagnostic assays, and epidemiological studies. The ethical procurement and meticulous management of biospecimens are critical elements that uphold the integrity of scientific research, enabling advancements in both pharmaceuticals and medical science.


List of Prominent Players in the Biospecimen Contract Research Services Market:

  • BioChain Institute,
  • BioIVT,
  • Boca Biolistics,
  • Creative Bioarray,
  • Cureline,
  • Discovery Life Sciences,
  • Infinity BiologiX,
  • Precision for Medicine, Inc.,
  • PrecisionMed, Inc.,
  • Medicover,
  • National BioService,
  • ICON plc,
  • The MT Group,
  • Eolas Biosciences Co. Ltd,
  • Indivumed GmbH,
  • Ardent Clinical Research Services,
  • Capital Biosciences, Inc.,
  • GR BioResearch,
  • Trans-Hit Bio (Azenta US, Inc.)
  • iSpecimen


Market Dynamics:



The rising incidence of chronic diseases, coupled with a shift towards personalized medicine and increased investment in pharmaceutical R&D, has driven substantial demand for biospecimen contract research services (BCRS). These services cater to the need for diverse and well-characterized biospecimen essential for researching disease mechanisms, discovering biomarkers, and developing targeted therapies. As the aging population grows globally, there is a heightened requirement for BCRS to support the study and treatment of conditions prevalent among elderly individuals, ensuring comprehensive research and development efforts in the healthcare sector.



Biospecimen contract research services encounter challenges with high costs spanning procurement, processing, storage, distribution, and regulatory compliance. Ensuring biospecimen quality and integrity is critical, requiring substantial investments in infrastructure and personnel. Strict adherence to ethical guidelines and regulatory requirements adds complexity and cost, emphasizing the importance of compliance for reliable research outcomes.


Regional Trends:

Pharmaceutical and biopharmaceutical companies in North America are increasingly outsourcing biospecimen-related services to reduce costs, gain specialized expertise, and focus on core competencies. This trend aligns with a significant rise in clinical trial activities in the region, driving demand for high-quality biospecimens to support research and development efforts. The popularity of precision medicine and genetic testing further boosts demand for well-characterized biospecimens annotated with clinical and molecular data, essential for biomarker discovery and personalized therapies. The region's high incidence of chronic diseases also fuels demand, with biospecimen contract research services providers meeting these needs and contributing to market growth.


Recent Developments:

  • In June 2024, Discovery Life Sciences is expanding its footprint with a new office and laboratory site in Malden, MA, marking its seventh facility in the United States and third in the Greater Boston area alongside Woburn and Quincy. This new site will focus on Gentest products and services, specializing in in vitro preclinical studies for drug metabolism and predictive toxicology, catering directly to the pharmaceutical and biotech industry.
  • In May 2024, Precision for Medicine completed a significant expansion of its laboratory campus in Frederick, Maryland, enhancing capacity and scale in biorepository and laboratory services. The facility now emphasizes capabilities in cell and gene therapy, oncology, and viral research, strengthening its support for advanced scientific initiatives.
  • In Sep 2022, BioIVT has acquired Fidelis Research, an 85-site clinical biospecimen collection network based in Sofia, Bulgaria, expanding its capabilities in Southeastern Europe. Fidelis Research offers cell isolation services and custom contract research solutions for pharmaceutical companies and clinical research organizations (CROs).


Segmentation of Biospecimen Contract Research Services Market-


By Biospecimen Types:

  • Oncological Studies
  • FFPE Tissue
  • Frozen Tissue
  • Plasma / Serum
  • Other Biospecimens
  • Non-Oncological Studies
  • Blood Products
  • Human Tissue
  • Other Biospecimens

By Therapeutic Area:

  • Oncological Disorders
  • Neurological Disorders
  • Cardiovascular Disorders
  • Other Therapeutic Areas


By Region-

North America-

  • The US
  • Canada
  • Mexico


  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe


  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa